No evidence of a significantly increased risk of transfusion-transmitted human immunodeficiency virus infection in Australia subsequent to implementing a 12-month deferral for men who have had sex with men (CME)

Transfusion

Volumn 50, Issue 12, 2010, Pages 2722-2730

  Seed, Clive R ^a   Kiely, Philip ^a   Law, Mathew ^a   Keller, Anthony J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUSTRALIA; BLOOD DONATION DEFERRAL; BLOOD DONOR; BLOOD TRANSFUSION; BODY PIERCING; CONTROLLED STUDY; ENDOSCOPY; HEMATOLOGICAL PROCEDURES; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MALE; MALE HOMOSEXUAL; RETROSPECTIVE STUDY; SURGERY; TATTOOING; UNSAFE SEX;

AUSTRALIA; BLOOD DONORS; BLOOD TRANSFUSION; DONOR SELECTION; HEALTH PLAN IMPLEMENTATION; HIV INFECTIONS; HIV-1; HOMOSEXUALITY, MALE; HUMANS; MALE; PREVALENCE; PREVENTIVE MEDICINE; PROGRAM EVALUATION; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TIME FACTORS;

EID: 78650020065     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02793.x     Document Type: Article

References (50)

1. Seed CR, Kiely P, Keller AJ,. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus. Intern Med J 2005; 35: 592-8.
2. Whyte GS, Savoia HF,. The effectiveness of donor selection for reducing the risk of HCV, HBV and HIV in new blood donors. Med J Aust 1997; 166: 611.
3. Polizzotto MN, Wood EM, Ingham H, Keller AJ,. Reducing the risk of transfusion-transmissible viral infection through blood donor selection: the Australian experience 2000 through 2006. Transfusion 2008; 48: 55-63.
4. Busch MP, Young MJ, Samson SM, Mosley JW, Ward JW, Perkins HA,. Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV-1 antibody screening. The Transfusion Safety Study Group. Transfusion 1991; 31: 4-11.
5. O'Brien SF, Ram SS, Vamvakas EC, Goldman M,. The Canadian blood donor health assessment questionnaire: lessons from history, application of cognitive science principles, and recommendations for change. Transfus Med Rev 2007; 21: 205-22.
6. O'Brien SF, Ram SS, Yi QL, Goldman M,. Donor's understanding of the definition of sex as applied to predonation screening questions. Vox Sang 2008; 94: 329-33.
7. Chiavetta JA, Deeks S, Goldman M, Hannon J, Leach-Bennett J, MegÃnn H, O'Brien S, Webert K,. Proceedings of a consensus conference: blood-borne HIV and hepatitis-optimizing the donor selection process. Transfus Med Rev 2003; 17: 1-30.
8. Gayle H,. An overview of the global HIV/AIDS epidemic, with a focus on the United States. AIDS 2000; 14 Suppl 2: S8-17.
9. Kleinman S,. HIV risk factors. In:, Eder A, Bianco C, editors. Screening blood donors: science, reason, and the donor history questionnaire. Bethesda (MD): AABB press; 2007. p. 121-140.
10. Australian Red Cross Blood Service. Submission to Australian Senate committee hearing on "Hepatitis C and the blood supply in Australia." Melbourne: Australian Red Cross Blood Service; 2003.
11. National Centre and HIV Epidemiology and Clinical Research. Annual Surveillance Report 2009: HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia 2009. Sydney, Australia: National Centre and HIV Epidemiology and Clinical Research, The University of New South Wales; 2009.
12. Wilson DP, Hoare A, Regan DG, Law MG,. Importance of promoting HIV testing for preventing secondary transmissions: modelling the Australian HIV epidemic among men who have sex with men. Sex Health 2009; 6: 19-33.
13. Musto JA, Seed CR, Law M, Keller AJ, Kaldor JM,. Estimating the risk of blood donation associated with HIV risk behaviours. Transfus Med 2008; 18: 49-54.
14. Leiss W, Tyshenko M, Krewski D,. Men having sex with men donor deferral risk assessment: an analysis using risk management principles. Transfus Med Rev 2008; 22: 35-57.
15. Vamvakas EC,. Why are all men who have had sex with men even once since 1977 indefinitely deferred from donating blood? Transfusion 2009; 49: 1037-42.
16. Hurley R,. Bad blood: gay men and blood donation. BMJ 2009; 338: b779.
17. AABB/America's Blood Centers/Amercan Red Cross. Donor deferral for men who have sex with another man (MSM). Joint statement before the Advisory Committee on Blood Safety and Availability. June 15, 2010. [monograph on the internet]. 2010. [cited 2010 Jul 9]. Available from: URL: http://www.aabb.org/ pressroom/statements/Pages/statement061510.aspx
18. New Zealand Blood Service Donor Deferral Criteria Review Group. Behavioural donor deferral criteria review: final report to the New Zealand blood service. Dunedin: Department of Preventative and Social Medicine, University of Otago; 2008. [cited 2010 Jul 9]. Available from: URL
19. Food and Drug Administration. Proceedings of the FDA workshop on behaviour based deferrals in the NAT era. Bethesda, MD, March 8 2006 Rockville, MD. 2006. [cited 2010 Jul 9]. Available from: URL
20. Brooks JP,. Should men who have ever had sex with men be allowed to give blood? No. BMJ 2009; 338: b318.
21. Roehr B,. Should men who have ever had sex with men be allowed to give blood? Yes. BMJ 2009; 338: b311.
22. Vamvakas EC,. Scientific background on the risk engendered by reducing the lifetime blood donation deferral period for men who have sex with men. Transfus Med Rev 2009; 23: 85-102.
23. Tasmanian Anti-Discrimination Tribunal. Anti-discrimination decisions-CAIN, Micheal v the AUSTRALIAN RED CROSS SOCIETY [monograph on the internet]. Hobart: Tasmanian magistrates court; 2009. [cited 2010 Jul 9]. Available from: URL
24. Canadian Blood Service. Canadian Blood Services defends charter rights claim on MSM policy [monograph on the internet]. 2009. [cited 2010 Jul 9]. Available from: URL: http://www.bloodservices.ca/CentreApps/Internet/UW-V502- MainEngine.nsf/page/Canadian-Blood-Services-defends-charter-rights-claim-on-MSM- policy?OpenDocument&CloseMenu
25. Soldan K, Sinka K,. Evaluation of the de-selection of men who have had sex with men from blood donation in England. Vox Sang 2003; 84: 265-73.
26. Germain M, Remis RS, Delage G,. The risks and benefits of accepting men who have had sex with men as blood donors. Transfusion 2003; 43: 25-33.
27. Velati C, Fomiatti L, Baruffi L, Romano L, Zanetti A, Iternational Society of Blood Transfusion. The risk of HIV transmission by transfusion in Italy does not increase after the abolition of ban on blood donations from homosexual men [abstract]. Vox Sang 2007; 93: 3-31.
28. Anderson SA, Yang H, Gallagher LM, O'Callaghan S, Forshee RA, Busch MP, McKenna MT, Williams I, Williams A, Kuehnert MJ, Stramer S, Kleinman S, Epstein J, Dayton AI,. Quantitative estimate of the risks and benefits of possible alternative blood donor deferral strategies for men who have had sex with men. Transfusion 2009; 49: 1102-14.
29. Vamvakas EC,. Relative safety of pooled whole blood-derived versus single-donor (apheresis) platelets in the United States: a systematic review of disparate risks. Transfusion 2009; 49: 2743-58.
30. Sanchez AM, Schreiber GB, Nass CC, Glynn S, Kessler D, Hirschler N, Fridey J, Bethel J, Murphy E, Busch MP,; Retrovirus Epidemiology Donor Study. The impact of male-to-male sexual experience on risk profiles of blood donors. Transfusion 2005; 45: 404-13.
31. Dayton A,. Point estimates of transfusion risk from quantitative models of deferral policy changes. Gaithersburg (MD): Department of Health and Human Services Food and Drug Administration Centre for Biologics Evaluation and Research; 2006.
32. National Centre and HIV Epidemiology and Clinical Research (editor). Annual Surveillance Report 2006: HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia 2006. Sydney: National Centre and HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, Australia; 2006.
33. Seed C, Cheng A, Kiely P, Keller AJ,. Recent trends in the incidence of acute HIV, HCV and HBV infection in repeat blood donors (abstract) Annual meeting of the Australian and New Zealand Society of Blood Transfusion. Gold Coast, Queensland, Australia, 2007.
34. O'Brien SF, Xi G, Yi QL, Goldman M,. Understanding non-disclosure of deferrable risk: a study of blood donors with a history of intravenous drug use. Transfus Med 2010; 20: 15-21.
35. Williams AE, Thomson RA, Schreiber GB, Watanabe K, Bethel J, Lo A, Kleinman SH, Hollingsworth CG, Nemo GJ,. Estimates of infectious disease risk factors in US blood donors. Retrovirus Epidemiology Donor Study. JAMA 1997; 277: 967-72.
36. Stigum H, Bosnes V, Orjasaeter H, Heier HE, Magnus P,. Risk behavior in Norwegian blood donors. Transfusion 2001; 41: 1480-5.
37. Seed C, Lee J, Buhring M, Keller A,. Do prospective blood donors understand HCV and HIV risk factors? The Australian experience [abstract]. Transfusion 2002; 42: 72S.
38. Orton SL, Stramer SL, Dodd RY, Alter MJ,. Risk factors for HCV infection among blood donors confirmed to be positive for the presence of HCV RNA and not reactive for the presence of anti-HCV. Transfusion 2004; 44: 275-81.
39. UK government Department of Health. Evidence-base for the exclusion of potential blood donors due to sexual behaviours associated with an increased risk of transfusion transmissible infections: a report to the Advisory committee on the Safety of Blood, Tissues and organs (SABTO) [monograph on the internet]. London; 2010. [cited 2010 Jul 9]. Available from: URL: http://www.dh.gov.uk/dr- consum-dh/groups/dh-digitalassets/@dh/@ab/documents/digitalasset/dh-111629.pdf
40. Busch M,. Closing the window on viral transmission. In:, Stramer SL, editor. Blood safety in the new millennium. Bethesda (MD): AABB Press; 2001. p. 33-54.
41. Soriano V, Dronda F, Gonzalez-Lopez A, Chaves F, Bravo R, Gutiérrez M, Heredia A, Hewlett I,. HIV-1 causing AIDS and death in a seronegative individual. Vox Sang 1994; 67: 410-1.
42. Coutlee F, Olivier C, Cassol S, Voyer H, Kessous-Elbaz A, Saint-Antoine P, He Y, Fauvel M,. Absence of prolonged immunosilent infection with human immunodeficiency virus in individuals with high-risk behaviors. Am J Med 1994; 96: 42-8.
43. Centers for Disease Control and Prevention (CDC). Persistent lack of detectable HIV-1 antibody in a person with HIV infection-Utah, 1995. MMWR Morb Mortal Wkly Rep 1996; 45: 181-5.
44. Mison L, Seed CR, Margaritis AR, Hyland C,. Nucleic acid technology screening of Australian blood donors for hepatitis C and human immunodeficiency virus-1 RNA: comparison of two high-throughput testing strategies. Vox Sang 2003; 84: 11-9.
45. Busch MP, Glynn SA, Stramer SL, Strong DM, Caglioti S, Wright DJ, Pappalardo B, Kleinman SH,; NHLBI-REDS NAT Study Group. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005; 45: 254-64.
46. Whyte GS, Savoia HF,. The risk of transmitting HCV, HBV or HIV by blood transfusion in Victoria. Med J Aust 1997; 166: 584-6.
47. Muller-Breitkreutz K,. Results of viral marker screening of unpaid blood donations and probability of window period donations in 1997. EPFA Working Group on Quality Assurance. Vox Sang 2000; 78: 149-57.
48. Seed CR, Cheng A, Ismay SL, Bolton WV, Kiely P, Cobain TJ, Keller AJ,; Virology Subcommittee of the National Donor and Product Safety Committee, Australian Red Cross Blood Service. Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT. Transfusion 2002; 42: 1365-72.
49. Ministerial Inquiry conducted by Professor Richard Smallwood in to the transmission of Human Immunodeficiency Virus (HIV) to a recipient of a homologous blood donation at the Royal Children's Hospital, Melbourne in December 1998 Senate. Melbourne: Victorian Government; 1999.
50. The Australian HIV Observational Database. Time trends in antiretroviral treatment use in Australia. Venereology 2001; 14: 162-8.